UBS Upgrades Corcept Therapeutics (CORT) to Neutral

May 13, 2026 4:27 AM

UBS analyst Ashwani Verma upgraded Corcept Therapeutics (NASDAQ: CORT) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found